When administered before cardiac ischemia (MB + ISQ group), MB significantly increased the concentration of CK (5891.1 ± 320.4 U/L, n = 4) and CK-MB (2446.6 ± 154.1 U/L, n = 4) compared with the SS + CIR group. The gene discussed is MB; the disease is myocardial ischemia.